09/18/2025 | Press release | Distributed by Public on 09/18/2025 14:01
Item 8.01 Other Events.
On September 17, 2025, the Board of Directors of Vivos Inc. (the "Company") approved the creation of Vivos Scientific India LLP ("Vivos India"), a wholly owned separate legal entity in India. Vivos India expands the Company's strategic initiatives, with the objective of establishing a manufacturing center, expanding human therapies and pursuing commercialization of therapies in India. In addition, we will generate additional human trial data to support our process with the Food and Drug Administration ("FDA").